"In an hour, they [dogs] can do thousands of sniffs; each sniff can evaluate a sample," says co-founder Akash Kulgod. Updated Monday Sep 07, 2026. When rescue dog Chloe is not tumbling across the grass on a farm outside India's tech capital Bengaluru, she is learning to sniff human breath for cancer with a little help from AI. Fitted with a 3D-printed helmet and harness packed with sensors, Chloe is part of experimental efforts to use dogs' extraordinary sense of smell to develop a non-invasive test for the disease. A growing body of global research suggests dogs can be trained to detect cancer and other human illnesses, from Parkinson's to Covid-19.
The Bengaluru-based startup Dognosis is using AI to analyse dogs' brain activity, respiration, and body language - turning their reaction to scent into data. "In an hour, they can do thousands of sniffs," co-founder Akash Kulgod, 26, told Reuters. "Each sniff can evaluate a sample." Dognosis hopes to launch commercially next year, which it says would make it the third company of its kind, after firms from Germany and Israel. Early detection can make a crucial difference to cancer survival rates, but in India, many patients are diagnosed only after the disease has advanced.
Dog sniffs could provide an easy and affordable first layer of screening to be deployed at scale, finding potential cases for further testing. As it chases commercial approval, Dognosis - backed by venture-capital firms including Accel India - is collaborating with government medical institutions for its research. Chloe, a Labrador mix, is one of 15 dogs being coached by the startup, clad in customised data-gathering helmets. "It's like a doggy 'Iron Man' suit," said Kulgod, who comes from a family of doctors and studied cognitive science at the University of California, Berkeley.
Research suggests diseases can alter the chemicals released by the body, creating distinctive odours. Dogs have around 300 million scent receptors, compared to about five million in humans. The testing method is simple: a patient breathes into a cotton mask for about 10 minutes, and the mask is then sealed in a bag and taken to the lab. Patients do not meet the dogs. A recent Dognosis study of more than 1,500 participants, involving six hospitals in Karnataka state, was published in the Journal of Clinical Oncology.
The company said it achieved an accuracy rate of more than 90% across seven major types of cancer, and now plans to test in real-world programmes. Cancer specialists in Bengaluru, independent of the project, voiced cautious optimism. "The study is promising, as an early signal," said Santhosh Kumar Devadas, head of oncology at Ramaiah Memorial Hospital. "But they need to do the study with a much larger group before we make any definitive conclusions." Neelesh Reddy, a senior consultant oncologist at Manipal Hospitals, noted that India has described cancer as a major public health concern, saying one in nine of its 1.4 billion people is likely to develop the disease.